Drug Shortage Report for BIO-GABAPENTIN

Last updated on 2020-11-06 History
Report ID 127830
Drug Identification Number 02450178
Brand name BIO-GABAPENTIN
Common or Proper name GABAPENTIN
Company Name BIOMED PHARMA
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 400MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-11-05
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-11-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 9450 BOUL. LANGELIER
MONTREAL, QUEBEC
CANADA H1P 3H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-11-06 English Compare
v2 2020-11-05 French Compare
v1 2020-11-05 English Compare

Showing 1 to 3 of 3